Workflow
Globenewswire
icon
搜索文档
LNTH DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
Globenewswire· 2025-10-08 13:50
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options If you suffered losses in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, ...
MOH SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
Globenewswire· 2025-10-08 13:45
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you suffered losses in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a lea ...
NUTX DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Globenewswire· 2025-10-08 13:40
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leadi ...
SLQT DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote
Globenewswire· 2025-10-08 13:35
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SelectQuote To Contact Him Directly To Discuss Their Options If you suffered losses in SelectQuote between September 9, 2020 and May 1, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, L ...
Boralex will release its 2025 third quarter financial results on November 7, at 11 a.m.
Globenewswire· 2025-10-08 13:30
MONTREAL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2025 third quarter results will take place on Friday, November 7, 2025, at 11 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Friday, November 7, 2025, at 11 a.m. ET To attend the conference Webcast link: https://edge.media-server.com/mmc/p/vr57urmw To attend the event by p ...
The Hottest Ticket in Town Will be Fireside at a VENU Amphitheater- 24/7 Market News
Globenewswire· 2025-10-08 13:30
From Firepits to Fortunes: VENU’s Amphitheatre Expansion Resonates with Billions in Development and DemandDENVER, Oct. 08, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that when autumn leaves start to change colors next year, concertgoers across Texas and Oklahoma will be sitting fireside at a VENU Amphitheatre, listening to their favorite artists under open skies. For many, it will feel ...
ProVen VCT plc: Issue of Equity and closure of offer for subscription
Globenewswire· 2025-10-08 13:30
ProVen VCT plc Issue of equity and closure of offer for subscription8 October 2025 The Directors of ProVen VCT plc announce an allotment on 8 October 2025 of ordinary shares of 10p each ("Ordinary Shares") pursuant to the offer for subscription that opened on 6 November 2024. 3,064,482 Ordinary Shares were allotted at an average price of 64.04p, based on the latest net asset value of 61.65p, being the net asset value per Ordinary Share as at 31 May 2025 adjusted for the dividend of 1.75p paid on 15 August ...
ProVen Growth and Income VCT plc: Issue of equity and closure of offer for subscription
Globenewswire· 2025-10-08 13:28
ProVen Growth and Income VCT plc (the “Company”)Issue of equity and closure of offer for subscription 8 October 2025 The Directors of ProVen Growth and Income VCT plc announce an allotment on 8 October 2025 of ordinary shares of 1.6187p each ("Ordinary Shares") pursuant to the offer for subscription that opened on 6 November 2024. 2,765,922 Ordinary Shares were allotted at an average price of 50.68p, based on the latest net asset value of 48.7p, being the net asset value per Ordinary Share as at 31 May 202 ...
SEALSQ Corp Announces 9M 2025 Preliminary Revenue and Key Financial Metrics
Globenewswire· 2025-10-08 13:28
Geneva, Switzerland, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Updates on Quantum Shield QS7001™ Launch in November 2025 and WISeSat 3.0 PQC Launch in the Same MonthReaffirms its FY 2025 Revenue Guidance of $17.5 Million – $20.0 Million, Representing a 59%–82% Year-on-Year GrowthNew Quantum-Resistant Offerings, Quantix Edge Partnership, and IC’ALPS Acquisition to Drive 2026 Revenue Surge and Global Expansion SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semico ...
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
Globenewswire· 2025-10-08 13:15
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures Intuitive expands AI and advanced imaging integration in Ion Endoluminal System Ion system during a procedure setup SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food & Drug Administration (FDA) has cleared software advancements fo ...